References
- Ryan F. The forgotten plague. How the battle against tuberculosis was won and lost, p. 3. Little, Brown, Boston 1993; 460
- World Health Organization. The World Health Organization Global Tuberculosis Program. http://www.who.int/gtb/. 2003.
- Kimerling ME, Kluge H, Vezhnina N, Iacovazzi T, Demeulenaere T, et al. Inadequacy of the current WHO re-treatment regiment in central Siberian prisons: treatment failure and MDR-TB. Int J Tuberc Lung Dis 1999; 3: 451–453
- De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999; 3: 457–465
- Tuberculosis: a global emergency. World Health Forum 1993; 14: 438.
- Global Alliance for Tuberculosis Drug Development. Scientific blueprint for TB drug development. Tuberculosis 2001;81(Suppl.): 1–52.
- Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005; 45: 529–564
- Kaplancıklı ZA, Turan-Zitouni G, Chevallet P. Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives. J Eny Inhib Med Chem 2005; 20: 179–182
- Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. 1997; 41: 1004–1009, Antimicrob Agents Chemother
- Masao K, Hiroshi T. 1,2,4-Triazole derivatives. Jpn. Pat, 21, (1986) 420, Chem. Abst. 1986; 105: 642097.
- Turan-Zitouni G, Kaplancıklı ZA, Kılıç FS, Erol K. The synthesis of some triazolylphenothiazine derivatives and their antidepressant and anxiolytic activities. Boll Chim Farm 2002; 141: 192–196
- Turan-Zitouni G, Kaplancıklı ZA, Erol K, Kılıç FS. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Il Farmaco 1999; 54: 218–223